The Asia-Pacific Journal of Ophthalmology

Asia-Pacific Journal of Ophthalmology:

Issue 1, January/February 2018 Review Article

Intravitreal Bevacizumab in Diabetic Retinopathy Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 Knobloch Lecture

Arevalo, J. Fernando; Liu, T.Y. Alvin; Pan-American Collaborative Retina Study Group (PACORES)



Author Information


From the Retina Division, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland.


Reprints: J. Fernando Arevalo, MD, FACS, Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Maumenee 708, Baltimore, MD 21287. E-mail: arevalojf@jhmi.edu.



Abstract


The advent of intravitreal anti-vascular endothelial growth factor (anti-VEGF) medications has revolutionized the treatment of diabetic eye diseases. Herein, we report the outcomes of clinical studies carried out by the Pan-American Collaborative Retina Study Group (PACORES), with a specific focus on the efficacy of intravitreal bevacizumab in the management of diabetic macular edema and proliferative diabetic retinopathy. We will also discuss the use of intravitreal bevacizumab as a preoperative, adjuvant therapy before vitrectomy for proliferative diabetic retinopathy.




Full Text

View PDF Online

Download PDF

APJO Express
2019
2018
2017
E-Newsletter+
2019
2018
2017
2016

More About APAO

  • http://www.apaophth.org/
  • http://2019.apaophth.org/
  • http://www.apaophth.org/apao-ldp/
  • http://www.apaophth.org/fellowship-program/
  • 1
  • 2
  • 3
  • 4
< >
All Rights Reserved © Asia-Pacific Academy of Ophthalmology  
Title×
Confirm
Cancel